Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
save over 85%
per week for 24 weeks
Welcome to
super saver spring
per week
for 24 weeks
// //

Marijuana plants for sale are displayed at the medical marijuana farmers market at the California Heritage Market in Los Angeles, Calif., on July 11, 2014.

David McNew/Reuters

A controversial pesticide banned in Canada has been discovered in products sold by a federally licensed medical marijuana producer, The Globe and Mail has learned, but neither the company nor Health Canada have informed the public.

Myclobutanil, a chemical that is also prohibited for use on legal cannabis in Colorado, Washington and Oregon because of health concerns, was found in product recently recalled by Mettrum Ltd., a Toronto-based medical marijuana company.

The pesticide is not approved for use on plants that are combusted, such as tobacco or cannabis, and is known to emit hydrogen cyanide when heated. Lawmakers in the three U.S. states moved quickly to ban myclobutanil, in some cases enacting emergency legislation when they discovered growers using it.

Story continues below advertisement

Read more: Ottawa should require marijuana to be lab-tested to ensure safety: task force

Read more: Ottawa plans to open up legal market for cannabis by 2019

Globe Investigation: What's in your weed? We tested dispensary marijuana to find out

But the lack of public disclosure by Health Canada raises new questions about what controls are in place to ensure the product is free of contaminants and chemicals, particularly as the government prepares to introduce legislation to legalize the drug next year.

A Globe investigation this summer called into question the department's ability to detect potentially dangerous contaminants, and revealed that Health Canada standards at the time did not require testing for myclobutanil and other banned chemicals.

The Mettrum discovery was made recently, when a random screening of the company's products by Health Canada turned up the unauthorized use of pyrethrin, a pesticide derived from the chrysanthemum plant that is also not approved for medical cannabis.

Mettrum issued a voluntary recall of the affected products on Nov. 1 and said the pyrethrin was used by mistake, because it was not listed on the ingredients of a spray the company was using.

Story continues below advertisement

But when Health Canada performed further tests on the samples, it also discovered they contained myclobutanil, which all producers know is a banned substance. However, for reasons that are not immediately clear, neither Health Canada nor Mettrum announced the findings to the public.

Instead, on Dec. 1, Mettrum issued a vague press release saying that "as a result of further testing and working with the full co-operation of Health Canada," the company was adding "a small number of additional product lots" to its previous voluntary recall. The company made no mention of myclobutanil.

It was only after The Globe was informed of automated phone messages Mettrum left with some of its customers, which made passing reference to myclobutanil during a lengthy recording, that a reporter called the company's customer service line to inquire.

A Mettrum employee said the recall was due to a "nutrient spray" that mistakenly contained pyrethrin. "We just want to be transparent," he said.

However, it was only after the employee was asked specifically if the recall also involved myclobutanil that he acknowledged the more controversial chemical had been found. "Yes, that was also included as well," the Mettrum employee said.

When Mettrum was later asked why the company hasn't acknowledged the discovery of the banned pesticide in a press release, the company said in a statement to The Globe that its plan to communicate only with customers was approved by Health Canada. The company said only "trace levels of myclobutanil" were found.

Story continues below advertisement

When asked why Health Canada did not provide disclosure to the broader public, the department said it determined that "exposure to the affected cannabis products would not likely cause any adverse health consequences," so no wider warning was necessary.

Health Canada did not explain how it determined there was no health risk, since microbiologists and lawmakers in the United States consider there to be no acceptable level of myclobutanil in cannabis.

Sold under the name Eagle 20 or Nova 40, the chemical is used to control a pest known as powdery mildew in crops such as grapes and berries, but is also known to be employed as a shortcut by illegal cannabis grow-operations when a crop is threatened by an infestation.

Myclobutanil is permitted in small doses on certain crops that are eaten, since the chemical compounds are metabolized by the digestive system and rendered non-toxic. It is also approved for crops that don't retain high levels of pesticide residue as they grow.

However, cannabis is much different. Like tobacco, it is usually smoked, not eaten, so any chemicals used on the plant are often inhaled directly into the lungs, and make their way directly into the bloodstream without being metabolized, or broken down, by the digestive system. As well, cannabis, due to its unique makeup, is known to retain more pesticide residue than many edible plants.

Policy makers in the United States acted quickly to clamp down on myclobutanil use when it was discovered a few years ago. Washington state enacted emergency legislation. In Colorado, the government ordered mass recalls, raided production facilities and threatened companies with large fines. Colorado also went public with the names of producers caught using the chemical.

Story continues below advertisement

"Myclobutanil cleaves off hydrogen cyanide," Andrew Freedman, director of marijuana co-ordination for the Colorado state government told The Globe this summer. "So yeah, we were concerned."

"For us it was a pretty easy answer … If you can't prove it's safe, then we shouldn't allow it to go out for human consumption," Mr. Freedman said.

When Health Canada was asked by The Globe in September what the government would do if a banned pesticide such as myclobutanil was found in product grown by one of the country's 37 licensed medical marijuana producers, the department said it had a zero-tolerance policy.

"If the Department had reason to believe that a licensed producer was using unauthorized pesticides or other chemicals, it would take immediate enforcement action," Health Canada said at the time. Such steps "could include detention of product, recalls or potentially revoking the producer's licence," Health Canada said, referencing two banned pesticides: myclobutanil and dodemorph.

A Globe investigation in September revealed that several unregulated cannabis dispensaries in Vancouver had sold products containing dodemorph, which is not approved "for any human use" and that Health Canada was told of the problem. However, Health Canada did not act, or warn the public, because it considers store-front dispensaries to be illegal, though the government does not prevent them from operating.

Mettrum did not say how the myclobutanil ended up in its product.

Story continues below advertisement

The use of potentially harmful chemicals in medical marijuana can be hazardous since the product is considered medicine and is sometimes used by patients with compromised immune systems. In Canada, there are only 13 pesticides approved for use on medical cannabis.

Health Canada said in a statement that it is "looking at ways to make all cannabis product recalls, regardless of the level of risk, publicly available." The department did not say why such concerns aren't made public now.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies